Aerodynamic characteristics of nebulized terbutaline sulphate using the Andersen Cascade Impactor compared to the Next Generation Impactor

References

• Boe J, Dennis J, O’Driscoll B, Members of Task Force, Bauer T, Carone M, et al. European Respiratory Society Guidelines on the use of nebulizers: Guidelines prepared by a European Respiratory Society Task Force on the use of nebulizers. Eur Respir J 2001;18(1):228–242.
   PubMed Web of Science ®Google Scholar
• Comité-Européen-Normalisation. Respiratory therapy equipment. Part 1: Nebulizing system and their componants. prEN 13544-1. CEN Brssels, Belgium. 2001:33–38.
   Google Scholar
• Jauernig J, Hug M, Knoch M. Contribution to the aerodynamic particle size assessment of nebulized drugs using the next generation impactor (NGI). Drug Delivery to the Lungs XIII Aerosol Society, New York. 2002:44–47.
   Google Scholar
• Jauernig J, Ohl S, Knoch M, Keller M. Effects of the test set-up formulation, and nebulizer type on aerodynamic droplet characteristics. Resp Drug Deliv 2004;IX:609–612.
   Google Scholar
• Mazhar S, Ismail N, Newton D, Chrystyn H. Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebuliser following an acute exacerbation. Brit J Clin Pharmacol 2008;65(3):334–337.
   PubMed Web of Science ®Google Scholar
• Abdelrahim ME, Chrystyn H. Aerodynamic characteristics of nebulized terbutaline sulphate using the Next Generation Impactor (NGI) and CEN method. J Aerosol Med Pulm Drug Deliv 2009;22(1):19–28.
   PubMed Web of Science ®Google Scholar
• British Pharmacopoeia. Preparations for inhalation. Aerodynamic assessment of fine particles-fine particle dose and particle size distribution (Ph. Eur. method 2.9.18). In: Stationery Office, editor. British Pharmacopoeia. London; 2005. p. A277–290.
   Google Scholar
• United States Pharmacopeia. Aerosols, nasal sprays, metered dose inhalers and dry powder inhalers. The United States pharmacopeia 28 [and] The national formulary 23: The board of trustees; 2005. pp 2359–2377.
   Google Scholar
• Nadarassan DK, Clark BJ, Assi K, Chrystyn H. Use of a mixing valve allows In-vitro characterisation of the emitted dose from a dry powder inhaler (DPI) using a low inhalation flow. J Aerosol Med 2007 2007;20(2):188.
   Google Scholar
• Finlay WH, Stapleton KW, Zuberbuhler P. Predicting regional lung dosages of a nebulized suspension: Pulmicort® (budesonide). Particul Sci Technol 1997;15(3):243–251.
   Web of Science ®Google Scholar
• Jauernig J, Schuschnig U, Hug M, Keller M. Validation of a test set-up utilizing the 28.3 L/min Andersen Cascade Impactor (ACI) for the aerodynamic assessment of nebulized aqueous formulations. Respiratory Drug Delivery VIII. 2002;2:537–539.
   Google Scholar
• Jauernig J, Schuschnig U, Hinrichs C, Hug M, Keller M. Comparative assessment of the aerodynamic droplet deposition pattern in an Andersen and Marple 298 impactor. J Aerosol Med 2001;14(3):405.
   Google Scholar
• Finlay WH, Stapleton KW. Undersizing of droplets from a vented nebulizer caused by aerosol heating during transit through an anderson impactor. J Aerosol Sci 1999;30(1):105–109.
   Web of Science ®Google Scholar
• Marple V, Roberts D, Jolyon M. A proposal for the use of the Next generation impactor (NGI) at flow rates between 15 and 30 L/min. Resp Drug Deliv 2004;IX:701–704.
   Google Scholar
• Marple V, Olson B, Santhanakrishnan K, Roberts D, Mitchell J, Hudson-Curtis B. Next Generation pharmaceutical Impactor: A new impactor for pharmaceutical inhaler testing. Part III. Extension of archival calibration to 15 L/min. J Aerosol Med 2004;17(4):335–343.
   PubMedGoogle Scholar
• Berg E, Svensson JO, Asking L. Determination of nebulizer droplet size distribution: A method based on impactor refrigeration. J Aerosol Med. 2007;20(2):97–104.
   PubMedGoogle Scholar
• Jauernig J, Ohl S, Luber M, Keller M. Differences in results obtained with the next generation impactor (NGI) for Pulmicort® suspension and according to the CEN standard EN13544-1 for a NaFSolution. Resp Drug Deliv 2003;XIV:41–44.
   Google Scholar
• Berg E, Asking L. Nebulizer droplet size distribution-refrigerated NGI at 15 L/min. Resp Drug Deliv 2004;IX:361–363.
   Google Scholar
• Dennis J, Berg E, Sandell D, Ali A, Lamb P, Tservistas M, et al. Cooling the NGI – an approach to size a nebulised aerosol more accurately. PharmEuropa Sci Notes 2008;1:27–30.
   Google Scholar
• Berg E, Lamb P, Ali A, Dennis J, Tservistas M, Mitchell J. Assessment of the need to coat particle collection cups of the NGI to mitigate droplet bounce when evaluating nebuliser-produced droplets. PharmEuropa Sci Notes 2008;1:21–26.
   Google Scholar
• Tservistas M, Reul K, Luithlen A, Friedrich I, Bucholski A, Keller M. Correlation of data from Andersen and Next Generation Impactor compared to laser diffractometry. J Aerosol Med 2006;19(2):231.
   Google Scholar
• Zhou Y, Brasel TL, Kracko D, Cheng Y-S, Ahuja A, Norenberg JP, et al. Influence of impactor operating flow rate on particle size distribution of four jet nebulizers. Pharmaceut Develop Technol 2007;12(4):353–359.
   PubMed Web of Science ®Google Scholar
• Van Oort M. In vitro testing of dry powder inhalers. Aerosol Sci Technol 1995;22(4):364–373.
   Web of Science ®Google Scholar
• Hinds WC. Aerosol technology: Properties, behavior, and measurement of airborne particles: New York: Wiley-Interscience; 1999.
   Google Scholar
• Waldrep JC, Berlinski A, Dhand R. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer. J Aerosol Med 2007;20(3):310–319.
   PubMedGoogle Scholar
• Garmise RJ, Hickey AJ. Calibration of the Andersen cascade impactor for the characterization of nasal products. J Pharm Sci 2008;97(8):3462–3466.
   PubMed Web of Science ®Google Scholar
• Bennett WD, Zeman KL. Sizing evaporative aerosols: The man with too many watches dilemma. J Aerosol Med Pulm Drug Deliv 2009;22(1):3–4.
   PubMed Web of Science ®Google Scholar
• Dennis J. Evolution of evaporative understanding within nebulizer standards. J Aerosol Med Pulm Drug Deliv 2009;22(1):5–8.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ahuja A, Irvin CM, Kracko DA, McDonald JD, Chen YS. Medical nebulizer performance: Effects of Cascade Impactor temperature. Respir Care 2005;50(8):1077
   PubMedGoogle Scholar